Production (Stage)
Elite Pharmaceuticals, Inc.
ELTP
$0.517
-$0.0022-0.42%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.32M | 8.29M | 9.56M | 8.41M | 7.11M |
| Total Receivables | 29.21M | 18.45M | 21.44M | 20.49M | 19.45M |
| Inventory | 16.24M | 20.16M | 14.16M | 13.83M | 12.93M |
| Prepaid Expenses | 976.40K | 1.14M | 130.40K | 435.70K | 524.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 57.74M | 48.05M | 45.29M | 43.16M | 40.01M |
|
|
|||||
| Total Current Assets | 57.74M | 48.05M | 45.29M | 43.16M | 40.01M |
| Net Property, Plant & Equipment | 14.10M | 13.87M | 14.28M | 14.77M | 14.61M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 289.00K | 289.00K | 289.00K | 289.00K | 289.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 24.26M | 28.55M | 28.34M | 29.63M | 28.74M |
| Total Assets | 96.39M | 90.76M | 88.20M | 87.85M | 83.65M |
|
|
|||||
| Total Accounts Payable | 2.96M | 5.84M | 1.98M | 2.61M | 2.71M |
| Total Accrued Expenses | 3.45M | 3.21M | 5.28M | 5.53M | 4.82M |
| Short-term Debt | 4.00M | 4.00M | 4.00M | 4.00M | 4.00M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.08M | 1.12M | 1.15M | 1.17M | 1.02M |
| Total Finance Division Other Current Liabilities | 346.20K | 514.80K | 433.10K | 712.40K | 498.70K |
| Total Other Current Liabilities | 346.20K | 514.80K | 433.10K | 712.40K | 498.70K |
| Total Current Liabilities | 11.84M | 14.69M | 12.85M | 14.01M | 13.05M |
|
|
|||||
| Total Current Liabilities | 11.84M | 14.69M | 12.85M | 14.01M | 13.05M |
| Long-Term Debt | 3.03M | 3.05M | 3.08M | 3.24M | 3.28M |
| Short-term Debt | 4.00M | 4.00M | 4.00M | 4.00M | 4.00M |
| Capital Leases | 2.80M | 3.00M | 3.17M | 3.25M | 3.44M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 25.20M | 33.57M | 21.84M | 9.08M | 6.30M |
| Total Liabilities | 42.87M | 54.31M | 40.93M | 29.60M | 26.07M |
|
|
|||||
| Common Stock & APIC | 174.53M | 174.45M | 174.38M | 174.33M | 174.28M |
| Retained Earnings | -120.70M | -137.70M | -126.81M | -115.77M | -116.39M |
| Treasury Stock & Other | -306.80K | -306.80K | -306.80K | -306.80K | -306.80K |
| Total Common Equity | 53.52M | 36.45M | 47.27M | 58.25M | 57.58M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 53.52M | 36.45M | 47.27M | 58.25M | 57.58M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 53.52M | 36.45M | 47.27M | 58.25M | 57.58M |
|
|
|||||